UK markets close in 2 hours 24 minutes

Novo Nordisk A/S (NONOF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
98.01+0.51 (+0.52%)
At close: 03:56PM EST
Sign in to post a message.
  • M
    MR.K
    What’s wrong every day going deep down ?
  • M
    MR.K
    Novo Nordisk settles securities lawsuits in Denmark . How that effects - affects to shareholders ?
  • E
    Edward
    I am snakebit . . . Just another stock I invested in this week that takes an unexpected hit . . . Supply issues is the first step as next comes lost sales from potential customers switching to competitors products
  • m
    mjr
    Good company, but overpriced given the competition in the diabetes market, particularly from Lilly. The market is correcting, ....Will consider buying at $80
  • A
    Alexander
    Added some shares today at $96 after cashing out some ATVI. No excitement planned till late Spring, bikini season will heat up sales.
  • h
    henry
    I warned everyone when I saw that pre-mkt trade @ $106, I didn't expect $100 or lower. They must have a really bad manufacturing problem that they're not publicly announcing for it to drop this much
  • h
    henry
    I saw $106 pre market last Friday, were heading back there tomorrow
  • C
    Charlie
    $125 before end of year, could even attract a big Pharma ex. PFE huge price $250 +++ demand to large and growing new suppliers to be announced
  • M
    MR.K
    Any forecast of wegovy sale growth or any new product to come up for the growth ?
  • h
    henry
    I told you yesterday I saw $106 Pre Mkt last Friday and posted that yesterday. Now it's $104 even worse pre mkt
  • p
    peachbacks
    Needs significant sales, profit growth to compete with many pharma companies at lower PE. I think Wegovy will carry the load. Best idea - just buy health ETF- my bad
  • B
    BetsyB
    This is a temporary hiccup due to the issue with the Wegovy syringe manufacturer. Competitor product (Lily) won't be out until 2024, so there is plenty of time for Wegovy to capture additional market share over the next two years. Wegovy is a game changer in the weight loss industry - with proven results. If anything, this is a buying opportunity.
  • M
    Mike
    I believe that part of the Ozempic demand is from a significant number of users using it off label for weight loss as it’s the same med (semaglutide) as Wegovy. Insurance companies that don’t cover Wegovy for weight loss cover Ozempic for A1C reduction.
    Eventually all insurance companies should cover Wegovy for weight loss or legislation will force it.
  • C
    C
    WATCH for possible breakout above 116.66, no resistance in area just above.
    Type: True breakout from triple resistance.
    Target: 123.74
  • I
    ItsMeLayla
    Can someone please Explain the share Price Crash for NovaNordisk too me it makes NO SENSE!
  • D
    DC
    Do not worry this is one of best run companies in whole world on par with Apple. They are expanding into more disease states. Obesity will be a 100 billion dollar total sales in years to come probably more
  • C
    Charlie
    weight loss,diabetes,makes this a $250 stock
  • h
    henry
    $120 by Christmas?
    $150 when Wegovy is approved for weight loss
    $200 when Wegovy becomes an oral drug instead of injection! Sign me up
    6"2 230. want to get to 210 without trying. LOL
  • L
    LesJ
    a "good" problem to have. too much demand. think of the backlog of orders thats coming. and they have no competitors other than jenny craig shakes
  • D
    DC
    NVO HAS their own pen manufacturing plant in Denmark for Insulin. Surprised haven't used some of that Wegovy.